Uso de modafinilo en astenia por cáncer avanzado

Between 46-90% of the 157 patients treated with 200 mg of modafinil had a significant improvement in fatigue. There were significant improvements in fatigue in two of the three randomised trials. Modafinil had a good tolerance in all of them. These results justify further research into the treatment of cancer-related fatigue, and meanwhile modafinil could be considered as an alternative for cancer - related fatigue.